Please login to the form below

Not currently logged in
Email:
Password:

Senior appointments at Glide Pharma

New chief financial officer and director of business development

Richard BungayGlide Pharma has appointed a chief financial officer and a director of business development as it prepares to scale up its commercial efforts.

Richard Bungay joins as chief financial officer from Verona, where he had served since September last year. Prior to this he was CEO of fellow UK biotech Chroma Therapeutics having previously been the company's chief financial officer.

His other previous include director of corporate communications and strategic planning at Celltech and finance director within the respiratory and inflammation therapy area at AstraZeneca.

New director of business development Tony Mills joins Glide from Q Chip where he was chief commercial officer.

Dr Mark Carnegie-Brown, Glide's CEO, commented: “Both are seasoned industry professionals, and attracting executives of their calibre is a testament to the progress Glide has made since completing a strategic fundraising last year for the scale-up of our device and formulation capabilities.”

9th July 2014

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN Healthcare

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

Solaris Health looks at the gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics